US8617181B2 - Methods for preparing a skin graft - Google Patents
Methods for preparing a skin graft Download PDFInfo
- Publication number
- US8617181B2 US8617181B2 US12/851,621 US85162110A US8617181B2 US 8617181 B2 US8617181 B2 US 8617181B2 US 85162110 A US85162110 A US 85162110A US 8617181 B2 US8617181 B2 US 8617181B2
- Authority
- US
- United States
- Prior art keywords
- substrate
- skin
- graft
- grafts
- blister
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 238000000034 method Methods 0.000 title claims abstract description 85
- 239000000758 substrate Substances 0.000 claims abstract description 211
- 239000000463 material Substances 0.000 claims description 26
- 230000033001 locomotion Effects 0.000 claims description 6
- 238000003306 harvesting Methods 0.000 abstract description 17
- 210000003491 skin Anatomy 0.000 description 101
- 210000001519 tissue Anatomy 0.000 description 26
- 238000005520 cutting process Methods 0.000 description 23
- 238000012546 transfer Methods 0.000 description 21
- 206010047642 Vitiligo Diseases 0.000 description 18
- 239000012530 fluid Substances 0.000 description 13
- 210000000434 stratum corneum Anatomy 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 206010052428 Wound Diseases 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 10
- 230000001070 adhesive effect Effects 0.000 description 9
- 210000004207 dermis Anatomy 0.000 description 9
- 239000000853 adhesive Substances 0.000 description 8
- 210000002615 epidermis Anatomy 0.000 description 8
- 210000002752 melanocyte Anatomy 0.000 description 8
- 230000007246 mechanism Effects 0.000 description 7
- 230000008439 repair process Effects 0.000 description 7
- 230000035614 depigmentation Effects 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 210000002510 keratinocyte Anatomy 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 208000014674 injury Diseases 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 239000012858 resilient material Substances 0.000 description 5
- 230000008733 trauma Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000009736 wetting Methods 0.000 description 4
- 206010060872 Transplant failure Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000037380 skin damage Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 210000000689 upper leg Anatomy 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 206010052779 Transplant rejections Diseases 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 210000000270 basal cell Anatomy 0.000 description 2
- 229960000074 biopharmaceutical Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000005461 lubrication Methods 0.000 description 2
- 210000000438 stratum basale Anatomy 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000009043 Chemical Burns Diseases 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010056340 Diabetic ulcer Diseases 0.000 description 1
- 206010014989 Epidermolysis bullosa Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 208000035901 Ischaemic ulcer Diseases 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 108010081750 Reticulin Proteins 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940107200 chondroitin sulfates Drugs 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000003981 ectoderm Anatomy 0.000 description 1
- 239000003256 environmental substance Substances 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000029774 keratinocyte migration Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229920000092 linear low density polyethylene Polymers 0.000 description 1
- 239000004707 linear low-density polyethylene Substances 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 208000009954 pyoderma gangrenosum Diseases 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000000250 revascularization Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229960003600 silver sulfadiazine Drugs 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 210000000273 spinal nerve root Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000000498 stratum granulosum Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/322—Skin grafting apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/10—Hair or skin implants
- A61F2/105—Skin implants, e.g. artificial skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00747—Dermatology
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00969—Surgical instruments, devices or methods, e.g. tourniquets used for transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/30—Surgical pincettes without pivotal connections
- A61B2017/306—Surgical pincettes without pivotal connections holding by means of suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/322—Skin grafting apparatus
- A61B2017/3225—Skin grafting apparatus with processing of harvested tissue
Definitions
- the present invention generally relates to methods for preparing a skin graft.
- Skin is the largest organ of the human body, representing approximately 16% of a person's total body weight. Because it interfaces with the environment, skin has an important function in body defense, acting as an anatomical barrier from pathogens and other environmental substances. Skin also provides a semi-permeable barrier that prevents excessive fluid loss while ensuring that essential nutrients are not washed out of the body. Other functions of skin include insulation, temperature regulation, and sensation. Skin tissue may be subject to many forms of damage, including burns, trauma, disease, and depigmentation (e.g., vitiligo).
- Skin grafts are often used to repair such skin damage.
- Skin grafting is a surgical procedure in which a section of skin is removed from one area of a person's body (autograft), removed from another human source (allograft), or removed from another animal (xenograft), and transplanted to a recipient site of a patient, such as a wound site.
- autograft a surgical procedure in which a section of skin is removed from one area of a person's body
- autograft removed from another human source
- xenograft xenograft
- Complications may include: graft failure; rejection of the skin graft; infections at donor or recipient sites; or autograft donor sites oozing fluid and blood as they heal. Certain of these complications (e.g., graft failure and rejection of the skin graft) may be mitigated by using an autograft instead of an allograft or a xenograft.
- a problem encountered when using an autograft is that skin is taken from another area of a person's body to produce the graft, resulting in trauma and wound generation at the donor site.
- the size of the graft matches the size of the recipient site, and thus a large recipient site requires removal of a large section of skin from a donor site.
- the size of the section of skin removed from the donor site increases, so does the probability that the donor site will not heal properly, requiring additional treatment and intervention.
- the size of the section of skin removed from the donor site increases, so does the possibility of infection.
- Such methods involve expanding a harvested graft on a substrate and applying the expanded substrate having the expanded graft to a recipient site.
- a problem associated with such techniques is that maintaining the substrate used for graft expansion in a stretched configuration results in stress on the substrate that is not optimal, which stress negatively affects interaction of the graft and the recipient site. Additionally, the stretched substrate may not retain the same properties as the unstretched configuration of the substrate, i.e., technological characteristics, such as physical, environmental and performance characteristics could be affected by the stretching of the substrate.
- the present invention generally relates to methods for preparing a skin graft that involve transferring a graft from a stretched first substrate to at least one other substrate.
- methods of the invention minimize manipulation and stress of the substrate that holds the graft to the recipient site, while still allowing for repair of a recipient site that is larger than a donor site from which the graft is obtained.
- methods of the invention involve harvesting a single graft or a plurality of skin grafts from a subject, applying the graft(s) to a first substrate, stretching or expanding the first substrate, and transferring the graft(s) from the first substrate to at least one other substrate for application to a patient recipient site.
- Methods of the invention minimize trauma and wound generation at a donor site, provide treatment for a recipient site that is larger than a donor site, and minimize manipulation and stress of a medical dressing that holds a graft to a recipient site.
- methods of the invention allow for preparing a skin graft for transfer to a recipient site without culturing the graft or applying biologics to the graft. Rather, certain methods of the invention use mechanical techniques for preparation of a skin graft, e.g. air pressure to stretch the substrate, thereby expanding the grafts.
- methods of the invention further include ensuring that the orientation of the skin grafts are maintained while transferring the grafts from the first substrate to the second substrate. Orientation of the graft may affect graft rejection.
- Harvesting of skin grafts can occur by any method known in the art.
- harvesting involves raising a plurality of blisters, and cutting the blisters to obtain a plurality of skin grafts.
- raising a plurality of blisters involves applying heat, vacuum pressure, or a combination thereof.
- the blister may be a fluid-filled blister (e.g. a suction blister).
- the blister is not fluid-filled, i.e., raised skin having only air within. Any type of raised blister (fluid-filled or not fluid-filled) may be used with methods of the invention.
- Methods of the invention are used to prepare any type of skin graft, such as an epidermal skin graft, a split thickness graft, or a full thickness graft.
- methods of the invention are used to prepare skin grafts including only or substantially only the epidermal layer of skin.
- Methods of the invention can be used for autografts, allografts, or xenografts.
- the grafts are autografts.
- methods of the invention involve transferring graft material from a first substrate to at least one additional substrate for application to a recipient site.
- more than one transfer of the grafts is performed, such as at least two transfers, at least three transfers, at least four transfers, or at least five transfers.
- the substrates can be the same, or different materials.
- the substrates are medical dressings.
- at least one of the substrates includes a biological or chemical substance, such as an antibiotic or growth factor.
- Methods of the invention are used to prepare skin grafts for any recipient site of damaged skin.
- exemplary types of skin damage include burns (e.g., thermal or chemical), infections, wounds, or depigmentation.
- the recipient site is an area of depigmented skin that has been prepared to receive a skin graft.
- FIG. 1 is a drawing showing the anatomy of skin.
- FIG. 2 panels A-C are schematics showing a device for generating and harvesting a plurality of micrografts.
- Panel A provides an exploded view of the device.
- Panel B provides a top view of the assembled device.
- Panel C provides a side view of the assembled device.
- FIG. 3 provides a schematic of an exemplary process for preparing a skin graft according to methods of the invention.
- Panel A shows an excised epidermal blister sitting on a sterile cutting surface with a sterile cutter tool above.
- Panel B shows the cutter tool cutting the epidermal blister to generate an array of micrografts.
- Panel C shows the array of micrografts that has been produced by the cutting tool sitting on a first substrate.
- Panel D shows the first substrate placed into an expansion device.
- a second substrate is placed into the assembly cap above.
- Panel E shows the expansion process. As the first substrate expands, the micrografts move apart.
- Panel F shows that as the first substrate flattens against the assembly cap, the micrografts are transferred to the second substrate.
- Panel G shows the completed expansion process and that the micrografts have been transferred to the second substrate.
- Panel H shows removal of the assembly cap having the second substrate and expanded micrografts from the expansion device.
- Panel I shows removal of the second substrate having the expanded micrografts from the assembly cap of the expansion device.
- FIG. 4 panels A-B are drawings showing a device of the invention for raising a suction blister.
- FIG. 5 panels A-D show different devices of the invention for raising a suction blister.
- FIG. 6 is a process chart showing steps for treating vitiligo using methods of the invention.
- the skin consists of 2 layers.
- the outer layer, or epidermis is derived from ectoderm, and the thicker inner layer, or dermis, is derived from mesoderm.
- the epidermis constitutes about 5% of the skin, and the remaining 95% is dermis.
- FIG. 1 provides a diagram showing the anatomy of skin. The skin varies in thickness depending on anatomic location, gender, and age of the individual.
- the epidermis the more external of the two layers, is a stratified squamous epithelium consisting primarily of melanocytes and keratinocytes in progressive stages of differentiation from deeper to more superficial layers.
- the epidermis has no blood vessels; thus, it must receive nutrients by diffusion from the underlying dermis through the basement membrane, which separates the 2 layers.
- the dermis is a more complex structure. It is composed of 2 layers, the more superficial papillary dermis and the deeper reticular dermis.
- the papillary dermis is thinner, including loose connective tissue that contains capillaries, elastic fibers, reticular fibers, and some collagen.
- the reticular dermis includes a thicker layer of dense connective tissue containing larger blood vessels, closely interlaced elastic fibers, and coarse, branching collagen fibers arranged in layers parallel to the surface.
- the reticular layer also contains fibroblasts, mast cells, nerve endings, lymphatics, and some epidermal appendages.
- Surrounding the components of the dermis is the gel-like ground substance composed of mucopolysaccharides (primarily hyaluronic acid), chondroitin sulfates, and glycoproteins.
- a substantially epidermal graft according to the invention is more likely to adapt to the characteristics of the recipient site.
- the present invention provides methods and devices for preparing and using skin grafts.
- the invention relates to preparing a skin graft for transfer to a recipient site without culturing the graft or applying biologics to the graft.
- methods of the invention involve harvesting a plurality of skin grafts from a subject, applying the grafts to a first substrate, stretching the first substrate, and transferring the grafts from the first substrate to a second substrate for application to a patient recipient site.
- Harvesting of the skin grafts may be accomplished by any technique known in the art, and the technique employed will depend on the type of graft required (e.g., epidermal graft, split thickness graft, or full thickness graft).
- An epidermal graft refers to a graft that consists of substantially epidermal skin and does not include any substantial portion of the dermal layer.
- a split thickness graft refers to a graft that includes sheets of superficial (epithelial) and some deep layers (dermal) of skin.
- a full-thickness graft refers to a graft that includes all of the layers of the skin including blood vessels.
- a device as shown in FIG. 2 panels A-C is used to obtain the plurality of skin grafts.
- Device 200 includes a frame 201 and a lid 202 . Fitted into the frame is a bottom plate 203 , a cutter grid plate 204 , a cutter plate 205 , and a top plate 206 .
- the bottom plate 203 , the cutter plate 205 , and the top plate 206 each include a hole array 211 . Once assembled, the hole array 211 of each of plates 203 , 205 , and 206 are aligned. The size of the holes in the hole array will depend on the size of the graft needed, with larger holes being used to produce larger grafts.
- a first substrate 207 interacts with the top plate 206 and will receive the harvested grafts.
- Device 200 further includes an actuation block 208 , actuation bar 209 , and actuation block guides 210 .
- Actuation components 208 , 209 , and 210 control movement of the cutter plate 205 .
- the frame 201 includes a vacuum stop 212 and the lid 202 includes a suction hole barb 213 . Once assembled, the frame 201 and lid 202 are arranged such that the vacuum stop 212 and the suction hole barb 213 are aligned with each other ( FIG. 1 panel B).
- a vacuum source is then connected to the device 200 such that negative pressure can be generated within the device.
- the device 200 can be held together by clamp screws 214 .
- Device 200 may also include a heating element.
- device 200 is placed on a donor site, such as an inner thigh of a patient.
- the vacuum source is turned on, producing negative pressure within device 200 .
- the negative pressure causes the skin to be pulled toward lid 202 , with a plurality of different portions of skin being pulled through each hole array 211 in each of plates 203 , 205 , and 206 .
- Such action results in generation of many microblisters.
- the blisters may or may not be fluid-filled. Any type of raised blister may be used with methods of the invention.
- actuation components 208 , 209 , and 210 are engaged to move cutter plate 205 .
- the movement of cutter plate 205 disrupts the alignment of the hole arrays 211 in each of plates 203 , 205 , and 206 , and results in cutting of the microblisters.
- the cut microblisters are captured on the first substrate 207 that is above top plate 206 . In this manner, there is provided a spaced apart array of micrografts.
- each micrograft will have a lateral dimension of less than about 2 mm e.g., 100 to 2000 microns.
- the first substrate is stretched or expanded, resulting in increased distance between the individual micrografts, moving them apart and resulting in production of a skin graft that can repair a recipient site that is larger than the donor site from which the grafts were obtained.
- the individual grafts themselves are not expanded, i.e., the graft tissue is not stretched; rather, stretching of the substrate increases the space or distance between each individual micrograft. Methods of the invention thus minimize tissue manipulation.
- the purpose of such processing is to use tissue from a donor site to cover a wound area that is larger than the donor site.
- the stretching of the substrate may be done manually, i.e., by hand, or may be done with the help of a machine.
- the stretching may be substantially uniform in all directions or may be biased in a certain direction. In a particular embodiment, the stretching is substantially uniform in all directions.
- Stretching of the substrate may be performed mechanically or may be accomplished by application of a pressurized fluid or gas. In certain embodiments, air pressure is used to expand the first substrate. Exemplary devices and methods are described in Korman (U.S. Pat. No. 5,914,264), the content of which is incorporated by reference herein in its entirety.
- any minimum distance can be provided between micrografts after the first substrate is stretched.
- the amount of stretching can be large enough to provide a sufficiently large area of substrate containing micrografts to allow a larger area of damaged tissue to be repaired using a particular amount of graft tissue removed from the donor site, i.e., the area of the stretched first substrate containing the separated micrografts can be much larger than the total area of the donor site.
- the distance between adjacent micrografts on the stretched first substrate can be greater than about 0.5 mm, although small separation distances may also be used.
- an amount of stretching can be applied to the first substrate such that the distance between adjacent micrografts is less than about 4 mm, because it is known that melanocytes, when grafted to a depigmented region, can migrate up to about 2 mm from each micrograft to repigment regions between the micrografts. This average distance can be larger if keratinocyte migration is involved with the tissue being treated because keratinocytes typically migrate greater distances compared to melanocytes.
- the ratio of the wound area to the donor site area is referred to as the expansion ratio.
- a higher expansion ratio is desirable to minimize the trauma of the donor site, and to aid patients who have only a small amount of tissue available for grafting purposes.
- the amount of area expansion e.g., the ratio of an area of damaged tissue that can be repaired compared to an area of graft tissue removed from a donor site, may be 500 ⁇ or more.
- the area of expansion may be from about 10 ⁇ to about 100 ⁇ , which provides a more uniform coverage and/or repigmentation of the recipient site.
- the micrografts may be smaller than those used to repair other types of damaged tissue, and thus the distances between adjacent micrografts may be greater after stretching of the first substrate.
- an area expansion of about 1000 ⁇ or more may be used.
- maintaining the first substrate in a stretched configuration may result in stress on the substrate that is not optimal.
- the stretched first substrate may not retain the same properties as the unstretched configuration of the first substrate, i.e., technological characteristics, such as physical, environmental and performance characteristics could be affected by the stretching of the substrate.
- methods used to maintain the substrate in its stretched condition may be physically cumbersome and prevent uniform application of the micrografts to uneven skin surfaces.
- the spaced apart micrografts are transferred to a second substrate. By transferring the micrografts to a second substrate, methods of the invention minimize manipulation and stress of the substrate that holds the graft to the recipient site.
- the second substrate After stretching the first substrate, the second substrate is brought into contact with the grafts on the stretched first substrate. Transfer is facilitated by the second substrate having greater affinity or more adhesive force toward the micrografts than the first substrate.
- the second substrate is coated with a hydrocolloid gel.
- the first substrate is wetted with a fluid such as water or a saline solution. Wetting the micrografts and the first substrate provides lubrication between the grafts and the first substrate and allows for easy transfer of the grafts from the first substrate to the second substrate. After wetting the first substrate, the grafts have greater affinity for the second substrate than the first substrate. The wetted first substrate is then removed from the second substrate and the grafts remain attached to the second substrate. The distance between the micrografts is maintained after transfer of the micrografts from the stretched first substrate to the second substrate.
- the first substrate may be made from any material that is biocompatible and capable of being stretched upon application of a moderate tensile force.
- the second substrate may be made from any material known in the art that is compatible with biological tissue.
- the second substrate may also be capable of being stretched upon application of a moderate tensile force.
- Exemplary materials for the first and/or second substrates include medical dressings, such as TEGADERM (medical dressing, commercially available from 3M, St. Paul, Minn.) or DUODERM (medical dressing, commercially available from 3M, St. Paul, Minn.).
- the first and/or second substrates may also be gas permeable.
- the first and/or second substrates include an adhesive on one side that facilitates attachment of the grafts to the substrates.
- the substrate material may have intrinsic adhesive properties, or alternatively, a side of the substrate may be treated with an adhesive material, e.g., an adhesive spray such as LEUKOSPRAY (Beiersdoerf GmbH, Germany).
- the first and second substrates are the same material.
- the first and second substrates are different materials.
- the materials of the first and second substrates are chosen to facilitate transfer of the micrografts from the first substrate to the second substrate.
- the material chosen for the first substrate has a weaker adhesive than the material chosen for the second substrate.
- the material of the first substrate is a deformable non-resilient material.
- a deformable non-resilient material refers to a material that may be manipulated, e.g., stretched or expanded, from a first configuration to a second configuration, and once in the second configuration, there is no residual stress on the substrate. Such materials may be stretched to an expanded configuration without returning to their original size, and thus in these embodiments it is not necessary to transfer the micrografts from a first substrate to a second substrate. Instead, the expanded first substrate including the micrografts is applied to a recipient site.
- Such deformable non-resilient materials tend to be soft, stiff or both soft and stiff. Softness is measured on the durometer scale.
- An example of such a material is a soft polyurethane.
- a soft polyurethane is produced is as follows. Polyurethanes in general usually have soft and hard segments. The hard segments are due to the presence of phenyl bridges. In a soft polyurethane, the phenyl bridge is switched out for an aliphatic, which is more flexible as its 6 carbon ring has no double bonds. Therefore, all the segments are soft. On the Durometer Scale, a soft polyethylene is rated about Shore 80 A.
- the expanded first substrate having the micrografts retains its expanded position without any residual stress, and the expanded first substrate is applied to a recipient site.
- the grafts and substrate are applied to a recipient of site of a patient.
- the site Prior to applying the grafts to the recipient site, the site is prepared to receive the grafts using any technique known in the art. Necrotic, fibrotic or avascular tissue should be removed. The technique used to prepare the site will depend on damage to the recipient site. For example, epidermal tissue, if present at the recipient site, can be removed to prepare the area for receiving the micrografts. Burned or ulcerated sites may not need removal of epidermal tissue, although some cleaning of the site or other preparation of the site may be performed. Wounds should be debrided and then allowed to granulate for several days prior to applying the graft. Most of the granulation tissue should be removed since it has a tendency to harbor bacteria. Applying silver sulfadiazine to the wound for 10 days prior to grafting reduces the bacterial count greatly.
- the size of the area at the recipient site can be about the same size as the area of the stretched first substrate having micrografts adhered thereto. This size generally will be greater than the area of the original graft tissue that was removed from the donor site to form the micrografts.
- the depigmented or damaged skin can be dermabraded with sandpaper or another rough material.
- the epidermal tissue can be removed from the recipient site by forming one or more blisters over the area to be treated, e.g., a suction blister or a freezing blister, and the raised epidermal blister tissue can then be removed by cutting or another procedure.
- the substrate having the micrografts can be placed over the area to be treated to form a dressing.
- a portion of the substrate having the micrografts can be positioned over the area to be repaired, e.g., the area from which the epidermal tissue has been abraded or removed for repigmentation.
- the substrate can be fixed in place over the treatment area, e.g., using tape or the like.
- the substrate can be removed after sufficient time has elapsed to allow attachment and growth of the micrografts in the treatment area, e.g., several days to a few weeks.
- FIG. 3 provides a schematic of an exemplary process for preparing a skin graft according to methods of the invention.
- Methods of the invention involve harvesting a single graft from a donor site, such as an epidermal graft.
- Harvesting of the skin grafts may be accomplished by any technique known in the art, and the technique employed will depend on the type of graft required (e.g., epidermal graft, split thickness graft, or full thickness graft).
- harvesting a skin graft involves raising a blister and cutting the blister.
- the blister may be a fluid-filled blister (e.g. a suction blister). In other embodiments, the blister is not fluid-filled. Any type of raised blister may be used with methods of the invention.
- suction blister grafting is used. Suction blister grafting involves raising a blister, and then cutting off the raised blister.
- An exemplary suction blister grafting technique is shown in Awad, (Dermatol Surg, 34(9):1186-1193, 2008), the content of which is incorporated by reference herein in its entirety. This article also shows various devices used to form suction blisters.
- a suction blister device is also described in Kennedy et al. (U.S. Pat. No. 6,071,247), the content of which is incorporated by reference herein in its entirety.
- An exemplary device is commercially available from Electronic Diversities (Finksburg, Md.).
- a device for raising a suction blister typically operates by use of suction chambers that are attached to a patient's skin.
- An instrument typically contains a power source, a vacuum pump, temperature controls and all related controls to operate multiple suction chambers.
- the suction chambers are connected to the console by a flexible connection.
- Each of the chambers is controlled by a preset temperature control to provide an optimal skin warming temperature. Both chambers share an adjustable common vacuum source that affects all chambers equally.
- Blister formation is accomplished by attaching the suction blister device to a patient's skin. Typically hook & loop fastener straps are used to keep the device in place.
- the chamber heating system provides a slight warming of an orifice plate of the device, which is in direct contact with the patient's skin surface.
- the application of a moderate negative pressure from the instrument console, to the chamber interior causes the patients skin to be gently drawn through the opening(s) in the orifice plate.
- the results are typical suction blisters, approximately the size of the opening(s) in the orifice plate.
- the skin and blister area is generally not damaged and patient discomfort is minimal.
- the negative pressure chamber is fabricated of mostly plastic components, with two removable threaded caps.
- the upper cap is fitted with a clear viewing lens so that the actual blister formation can be observed.
- the opposite end of the chamber is fitted with a removable orifice plate that is placed on the patient's skin. Since this plate is simply threaded onto the chamber end, multiple plates with different opening patterns can be interchanged as desired.
- the interior of the device is warmed and illuminated by an array of low voltage incandescent lamps.
- This lamp array is controlled from the instrument console temperature controller, cycling as needed, to maintain the set point temperature.
- the heat from these lamps is radiated and conducted to the orifice plate, which then warms the patient's skin.
- the chamber is connected to the console via a composite vacuum and low voltage electrical system. Quick connections are used for the vacuum and electrical system to facilitate removal and storage.
- the Negative Pressure Instrument console is a self-contained fan cooled unit which is designed to operate on 120 VAC 60 Hz power. Vacuum is supplied by an industrial quality diaphragm type vacuum pump, capable of a typical vacuum of 20 in Hg (0-65 kpa) at 0 CFM. An analog controller that is preset to 40° C. provides the temperature control for each suction chamber. This provides accurate control of the orifice plate temperature.
- the instrument console has internal adjustments that allow the user to recalibrate the temperature setting if desired. Other temperatures can be preset if desired.
- the front panel includes a vacuum gauge and vacuum bleeder adjustment to regulate the vacuum to both chambers. The console front panel also contains the connections for the chamber assemblies.
- FIG. 3 panel A shows an excised skin graft on a first substrate, with a sterile cutting tool above the graft.
- the cut blister is placed onto a sterile surface, such as a glass slide, and the array of micrografts is generated on the sterile surface prior to transfer to the first substrate.
- the cut blister is trapped between two aligned metal screens.
- the screens are pushed together to cut the blister into an array of micrografts.
- the micrografts are then pushed out of the screens and deposited onto the first substrate using an array of pushers whose size and spacing correspond to the metal screens.
- the cut blister is harvested directly between the two screens for generation of the array of micrografts.
- the cut blister is harvested directly into a shear or punch and die device for generation of micrografts.
- a shear or punch die includes an array of flat-faced piston-like components that fit closely into the openings in a metal screen/mesh.
- the cut graft is harvested onto the array of pistons, and sits between the array of pistons and the screen/mesh.
- the screen/mesh is closed over the cut blister and force is applied to the array of pistons.
- the pistons push through the holes in the screen/mesh and in the process, portions of tissue are punched out from the openings of the screen/mesh and deposited on a substrate, producing an array of micrografts on a substrate.
- Such embodiments allow for simultaneous generation of the array of micrografts and deposition of the array of micrografts onto the substrate.
- the array of micrografts can be generated by making cuts or using other protocols to form the array of micrografts from the single graft.
- the cuts may pass partially or completely through the graft tissue.
- the micrografts used may have a presence of melanocytes.
- a lateral dimension of such micrografts can be between less than about 1 mm, e.g., 200 to 1000 microns. Other exemplary sizes are between 400 and 800 microns.
- the area of the micrografts can be between about 0.04 mm 2 and about 1 mm 2 .
- the exemplary sizes can provide micrografts large enough such that each micrograft is likely to contain some melanocytes, yet small enough to provide a large number of micrografts from a particular piece of graft tissue, which can facilitate a significant degree of expansion on the graft site.
- micrograft sizes may be smaller.
- a lateral dimension of micrografts containing keratinocytes can be between about 50 microns and about 1000 microns, or between 100 microns and about 800 microns.
- the area of such micrografts can be between about 0.0025 mm 2 and about 1 mm 2 .
- the exemplary size ranges provide micrografts large enough to contain viable and undamaged keratinocytes, and small enough to facilitate repair of a larger area of damaged skin.
- FIG. 3 panel B shows an exemplary cutting tool.
- the cutting tool may be configured in any manner, and such configuration will depend upon the size of the micrografts to be produced and the desired array pattern.
- the cutting tool includes a plurality of adjacent blades. The arrangement of the blades will depend upon the desired pattern for the array of micrografts.
- the tool shown in FIG. 3 panel B is configured to produce a square grid of micrografts (See FIG. 3 panel C).
- the spacing of the blades in the cutting tool will depend on the desired size of the micrografts. For example, the blades may be spaced about 100 to 2000 microns apart, or about 500 to 1000 microns apart.
- the cutting tool is pressed at least once into the skin graft on the first substrate to produce the array of micrografts (See FIG. 3 panels B and C).
- mesh devices include rigid, biocompatible material, such as stainless steel.
- the mesh includes a plurality of openings. The openings are sized to provide an array of micrografts of a desired size, such as lateral sizes between about 100 microns and about 1000 microns or about 300 microns to about 500 microns. Similar to the cutting tool described above, the mesh is pressed at least once into the skin graft to produce the array of micrografts.
- FIG. 3 panels D-I show remaining steps of the method.
- the distance between the micrografts is expanded. Expansion results in increased distance between the individual micrografts, moving them apart and resulting in production of a skin graft that can repair a recipient site that is larger than the donor site from which the grafts were obtained. Expansion may be performed as described above.
- the second substrate is brought into contact with the grafts on the stretched first substrate for transfer of the micrografts from the expanded first substrate to the second substrate. Transfer may be performed as described above.
- the distance between the micrografts is maintained after transfer of the micrografts from the stretched first substrate to the second substrate.
- the grafts and substrate are applied to a recipient of site of a patient. Preparation of the recipient site and application of the array of micrografts to the prepared recipient site may be performed as described above.
- transfer to a second substrate is not necessary because the material of the first substrate is a deformable non-resilient material.
- a deformable non-resilient material refers to a material that may be manipulated, e.g., stretched or expanded, from a first configuration to a second configuration, and once in the second configuration, there is no residual stress on the substrate. Such materials may be stretched to an expanded configuration without returning to their original size. Exemplary materials are described above.
- the expanded first substrate having the micrografts retains its expanded position without any residual stress, and the expanded first substrate is applied to a recipient site. Preparation of the recipient site and application of the array of micrografts to the prepared recipient site may be performed as described above.
- Epidermal skin includes a stratum corneum layer and a basal layer.
- the stratum corneum refers to the outermost layer of the epidermis, composed of large, flat, polyhedral, plate-like envelopes filled with keratin, which is made up of dead cells that have migrated up from the stratum granulosum. This layer is composed mainly of dead cells that lack nuclei.
- the thickness of the stratum corneum varies according to the amount of protection and/or grip required by a region of the body. In general, the stratum corneum contains 15 to 20 layers of dead cells, and has a thickness between 10 and 40 ⁇ m.
- the basal layer refers to the deepest layer of the 5 layers of the epidermis.
- the basal layer is a continuous layer of live cells and can be considered the stem cells of the epidermis. These cells are undifferentiated and proliferative, i.e., they create daughter cells that migrate superficially, differentiating during migration. Keratinocytes and melanocytes are found in the basal layer.
- the graft For a graft to become integrated at a recipient site, the graft must be able to receive nutrients. Since the cells of the basal layer are live cells, orienting an epidermal graft such that the basal layer interacts with the recipient site allows the graft to receive nutrients, and thus remain viable. In contrast, since the cells of the stratum corneum are dead cells, orienting an epidermal graft such that the stratum corneum layer interacts with the recipient site prevents the graft from receiving nutrients, resulting in death of the graft tissue and graft failure. Methods of the invention ensure that during the grafting process, the basal layer of a graft interacts with the recipient site of a patient, allowing for the graft to receive nutrients and thus remain viable.
- Certain methods involve harvesting an epidermal skin graft, and applying the epidermal skin graft to a recipient site such that the basal layer of the skin graft makes direct contact with the recipient site.
- Harvesting may be accomplished by creating a blister, such as a suction blister.
- Suction blister grafting is described above.
- a vacuum is used to hold the stratum corneum side of the blister, which can be released when the blister is deposited onto the cutting surface.
- an adhesive side of a substrate is placed in contact with the stratum corneum layer of the raised blister.
- the stratum corneum layer of the graft becomes adhered to the substrate, and the basal layer is orientated away from the substrate.
- Such a technique ensures that the basal layer of the graft is oriented away from the substrate and is thus available to interact with the recipient site of a patient.
- Other methods of the invention involve harvesting a skin graft from a donor site, placing the skin graft on a first substrate such that basal cells of the graft make direct contact with the first substrate, transferring the graft from the first substrate to a second substrate such that the basal cells do not directly contact the second substrate, and applying the second substrate to a recipient site.
- Harvesting may be accomplished by creating a blister, such as a suction blister.
- Suction blister grafting is described above. The blister is cut and the basal layer of the graft is contacted to an adhesive side of a first substrate. The basal layer of the graft becomes adhered to the first substrate and the stratum corneum layer is orientated away from the first substrate, and is available for interaction with a second substrate.
- an adhesive side of a second substrate is brought into contact with the stratum corneum layer of the graft that is adhered to the first substrate. Transfer to the second substrate is accomplished as described above.
- the first substrate is wetted with a fluid such as water or a saline solution. Wetting the graft and the first substrate provides lubrication between the graft and the first substrate and allows for easy transfer of the graft from the first substrate to the second substrate. After wetting the first substrate, the graft has a greater affinity for the second substrate than the first substrate. The wetted first substrate is then removed from the second substrate and the grafts remain adhered to the second substrate.
- a fluid such as water or a saline solution
- the stratum corneum layer of the graft becomes adhered to the second substrate, and the basal layer is orientated away from the second substrate.
- Such a technique ensures that the basal layer of the graft is oriented away from the second substrate and is thus available to interact with the recipient site of a patient.
- Devices of the invention include a hollow body having a distal end configured for placement on skin, a mechanism for raising a blister, and a cutter integrated in the body for cutting the blister produced on the skin.
- a device as shown in FIG. 4 panel A is used to obtain a skin graft.
- Device 400 includes a hollow body 401 and a mechanism for raising a blister 402 .
- Hollow body 401 includes a distal end 403 that is configured for placement on the skin.
- Such a distal end may include an orifice plate 404 .
- Orifice plate 404 determines the size and the shape of the blister or blisters that will be raised.
- Orifice plate 404 may be any shape or size and will depend on the blister or blisters to be raised.
- the diameter or lateral dimension of the blister may be from about 6 mm to about 12 mm, although larger or smaller blister sizes may be used.
- the mechanism for raising a blister may be a vacuum component, a heating component, or a combination thereof.
- An exemplary heating component is a light source.
- mechanism 402 is a combination of a vacuum component and a heating component.
- the hollow body 401 further includes a cutter 405 , which includes cutter plate 406 and a hole 407 ( FIG. 4 panel B).
- Device 400 further includes an actuation block 408 , actuation bar 409 , and actuation block guides 410 .
- Actuation components 408 , 409 , and 410 control movement of the cutter 405 .
- Blister formation is accomplished by attaching the distal end 403 of hollow body 401 to donor site of a patient, such as an inner thigh of a patient. Hook and loop fastener straps may be used to keep the device in place.
- the heating component of blister raising mechanism 402 provides a slight warming of orifice plate 404 , which is in direct contact with the patient's skin surface.
- the application of a moderate negative pressure to the chamber interior from the vacuum component of blister raising mechanism 402 results in the patient's skin being gently drawn through the opening in orifice plate 404 .
- the result is a blister or blisters, approximately the size of the opening in orifice plate 404 .
- the produced blister may be fluid-filled or may not contain any fluid, i.e., a blister having air within.
- the skin and blister area is generally not damaged and patient discomfort is minimal.
- the cutter 405 is positioned in hollow body 401 such that upon raising the blister, at least a portion of the blister protrudes through hole 407 in cutter plate 406 .
- the actuation components 408 , 409 , and 410 are engaged to move cutter plate 406 .
- the movement of cutter plate 406 disrupts the alignment of hole 407 with the other components of device 400 , and results in cutting of the raised blister.
- FIG. 5 panel A shows a device 500 that further includes a chamber 511 for capturing the cut blister.
- Chamber 511 is positioned in hollow body 501 and above cutter 505 .
- Hollow body 501 includes a distal end 503 that is configured for placement on the skin. Such a distal end may include an orifice plate 504 .
- the device 500 also includes a mechanism for raising a blister 502 .
- the hollow body 501 further includes a cutter 505 , which includes cutter plate 506 and a hole 507 ( FIG. 5 panel B).
- Device 500 further includes an actuation block 508 , actuation bar 509 , and actuation block guides 510 . Actuation components 508 , 509 , and 510 control movement of the cutter 505 .
- Chamber 511 may be removable from device 500 .
- Chamber 511 may include multiple configurations.
- chamber 511 may include a retractable bottom. The bottom is in an open position when chamber 511 is inserted into hollow body 501 . In the open position, chamber 511 is able to receive the cut blister. Once the cut blister is in chamber 511 , the bottom of the chamber is closed, capturing the blister in chamber 511 . Chamber 511 may then be removed from device 500 .
- chamber 511 includes a substrate 512 ( FIG. 5 panel C).
- device 500 is configured such that substrate 512 is positioned in chamber 511 so that upon raising the blister, a portion of the blister contacts the substrate and becomes attached to the substrate.
- Cutter 505 then cuts the blister, and the cut blister becomes attached to the substrate 512 in chamber 511 .
- Chamber 511 is then removed from device 500 , and substrate 512 may be removed from chamber 511 .
- a vacuum instead of a substrate, is used to hold the cut blister within the chamber.
- device 500 does not use a chamber, rather a substrate 512 is directly integrated with device 500 in order to capture the cut blister ( FIG. 5 , panel D). Once captured, substrate 512 having an attached cut blister may be removed from device 500 .
- Methods of the invention may be used to prepare a skin graft to repair numerous different types of skin damage.
- methods of the invention may be used to prepare grafts to treat burns (e.g., both thermal and chemical burns), blistering, dermatological conditions (e.g., epidermolysis bullosa or pyoderma gangrenosum), radiation therapy ulcers, diabetic ulcers, ischemic ulcers, trophic ulcers, trauma, or depigmentation (e.g., vitiligo).
- methods of the invention are used to prepare a skin graft(s) to treat vitiligo.
- Vitiligo is a chronic disorder that causes depigmentation of patches of skin. It occurs when melanocytes, the cells responsible for skin pigmentation, die or are unable to function. Although patches are initially small, they often enlarge and change shape. When skin lesions occur, they are most prominent on the face, hands and wrists. Some lesions have hyper-pigmentation around the edges. Depigmentation is particularly noticeable around body orifices, such as the mouth, eyes, nostrils, genitalia and umbilicus.
- Vitiligo is generally classified into two categories, non-segmental vitiligo and Segmental vitiligo.
- non-segmental vitiligo NSV
- Vitiligo where little pigmented skin remains is referred to as vitiligo universalis.
- Non-segmental vitiligo can come about at any age, unlike segmental vitiligo which is far more prevalent in teenage years.
- Segmental vitiligo differs in appearance, aetiology and prevalence from associated illnesses. Its treatment is different from that of non-segmental vitiligo. It tends to affect areas of skin that are associated with dorsal roots from the spine. It spreads much more rapidly than non-segmental vitiligo and, without treatment, it is much more stable/static in course and not associated with auto-immune diseases.
- FIG. 6 is a process chart showing steps for treating vitiligo using methods of the invention.
- an autograft is provided to the site of depigmented skin.
- the graft includes melanocytes, and thus upon the recipient site accepting the graft, the graft will produce pigmented skin at the recipient site.
- a donor site of pigmented skin is aseptically cleaned prior to harvesting of a skin graft. Standard methods are used to clean the donor site.
- a typical donor site is an inner thigh, but any area of pigmented skin may be used.
- a skin grafted is harvested by raising a blister, such as a suction blister, and cutting the blister.
- a blister such as a suction blister
- Devices described herein may be used to raise and cut the blister.
- commercially available blister devices may be used.
- the epidermal blister is placed onto a sterile cutting apparatus and divided into an array of micrografts.
- the micrografts are transferred to a first substrate for expansion. Transfer may occur as described above.
- the cut blister is placed directly onto the first substrate and the array of micrografts are generated directly on the first substrate.
- the micrografts are expanded as the surface area of the first substrate is expanded.
- the expanded micrografts are transferred to a second substrate.
- FIG. 6 shows an exemplary substrate, TEGADERM (medical dressing, commercially available from 3M, St. Paul, Minn.). However, any biocompatible substrate may be used.
- the area of depigmented skin i.e., the recipient site
- the second substrate including the expanded micrografts is applied to the dermabraded recipient site.
- the donor site and the recipient site are dressed and wound care is provided.
Abstract
Description
Claims (20)
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/851,621 US8617181B2 (en) | 2010-08-06 | 2010-08-06 | Methods for preparing a skin graft |
KR1020187020063A KR20180085048A (en) | 2010-08-06 | 2011-08-05 | Devices for preparing a skin graft |
CA2807411A CA2807411C (en) | 2010-08-06 | 2011-08-05 | Devices for preparing a skin graft |
KR1020137005595A KR101880313B1 (en) | 2010-08-06 | 2011-08-05 | Devices for preparing a skin graft |
AU2011285592A AU2011285592B2 (en) | 2010-08-06 | 2011-08-05 | Methods for preparing a skin graft |
CN201610416674.9A CN105997199B (en) | 2010-08-06 | 2011-08-05 | It is used to prepare the device of skin graft |
BR112013002642-1A BR112013002642B1 (en) | 2010-08-06 | 2011-08-05 | device to obtain a skin graft |
CN201180046197.7A CN103402446B (en) | 2010-08-06 | 2011-08-05 | For the method preparing skin graft |
JP2013523358A JP5878173B2 (en) | 2010-08-06 | 2011-08-05 | How to prepare a skin graft |
RU2013107157/14A RU2587906C2 (en) | 2010-08-06 | 2011-08-05 | Methods of preparing a skin graft |
EP11815367.5A EP2600779B1 (en) | 2010-08-06 | 2011-08-05 | Devices for preparing a skin graft |
SG2013006390A SG187216A1 (en) | 2010-08-06 | 2011-08-05 | Methods for preparing a skin graft |
PCT/US2011/046737 WO2012019094A2 (en) | 2010-08-06 | 2011-08-05 | Methods for preparing a skin graft |
US13/839,518 US9610093B2 (en) | 2010-08-06 | 2013-03-15 | Microblister skin grafting |
AU2016204210A AU2016204210B2 (en) | 2010-08-06 | 2016-06-21 | Methods for preparing a skin graft |
US15/439,289 US10537355B2 (en) | 2010-08-06 | 2017-02-22 | Microblister skin grafting |
AU2018256579A AU2018256579A1 (en) | 2010-08-06 | 2018-10-31 | Methods for preparing a skin graft |
US16/748,756 US20200155187A1 (en) | 2010-08-06 | 2020-01-21 | Microblister skin grafting |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/851,621 US8617181B2 (en) | 2010-08-06 | 2010-08-06 | Methods for preparing a skin graft |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/851,703 Continuation-In-Part US8926631B2 (en) | 2010-08-06 | 2010-08-06 | Methods for preparing a skin graft without culturing or use of biologics |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/851,682 Continuation-In-Part US9597111B2 (en) | 2010-08-06 | 2010-08-06 | Methods for applying a skin graft |
US12/851,656 Continuation-In-Part US8562626B2 (en) | 2010-08-06 | 2010-08-06 | Devices for harvesting a skin graft |
US13/839,518 Continuation-In-Part US9610093B2 (en) | 2010-08-06 | 2013-03-15 | Microblister skin grafting |
Publications (2)
Publication Number | Publication Date |
---|---|
US20120035618A1 US20120035618A1 (en) | 2012-02-09 |
US8617181B2 true US8617181B2 (en) | 2013-12-31 |
Family
ID=45556677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/851,621 Active 2030-09-04 US8617181B2 (en) | 2010-08-06 | 2010-08-06 | Methods for preparing a skin graft |
Country Status (10)
Country | Link |
---|---|
US (1) | US8617181B2 (en) |
EP (1) | EP2600779B1 (en) |
JP (1) | JP5878173B2 (en) |
KR (2) | KR101880313B1 (en) |
CN (2) | CN105997199B (en) |
AU (2) | AU2016204210B2 (en) |
BR (1) | BR112013002642B1 (en) |
CA (1) | CA2807411C (en) |
SG (1) | SG187216A1 (en) |
WO (1) | WO2012019094A2 (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9451979B2 (en) | 2008-09-24 | 2016-09-27 | The General Hospital Corporation | Method and apparatus for grafting of skin tissue |
US9517082B2 (en) * | 2010-08-06 | 2016-12-13 | Kci Licensing, Inc. | Methods for preparing a skin graft without culturing or use of biologics |
US9610093B2 (en) | 2010-08-06 | 2017-04-04 | Kci Licensing, Inc. | Microblister skin grafting |
WO2017143229A1 (en) | 2016-02-19 | 2017-08-24 | Kci Licensing, Inc. | Transfected epidermal grafts and methods of making the same |
US9848908B2 (en) | 2011-12-07 | 2017-12-26 | Kci Licensing, Inc. | Devices for generating skin grafts |
US9962254B2 (en) | 2013-03-14 | 2018-05-08 | Kci Licensing, Inc. | Absorbent substrates for harvesting skin grafts |
WO2018102342A1 (en) | 2016-11-29 | 2018-06-07 | Kci Licensing, Inc. | Identification and visualization of micrografts for monitoring epithelialization |
US9993261B2 (en) | 2013-12-31 | 2018-06-12 | Kci Licensing, Inc. | Sensor systems for skin graft harvesting |
US10174279B2 (en) | 2015-11-19 | 2019-01-08 | Electronics And Telecommunications Research Institute | Apparatus and method for expanding skin |
US10463392B2 (en) | 2013-12-31 | 2019-11-05 | Kci Licensing, Inc. | Fluid-assisted skin graft harvesting |
WO2020223492A1 (en) * | 2019-04-30 | 2020-11-05 | Srgi Holdings Llc | Pixel array medical systems, devices and methods |
US10912861B2 (en) | 2015-04-09 | 2021-02-09 | Kci Licensing, Inc. | Soft-tack, porous substrates for harvesting skin grafts |
US11006974B2 (en) | 2015-11-03 | 2021-05-18 | Kci Licensing, Inc. | Devices for creating an epidermal graft sheet |
US11083487B2 (en) | 2010-08-06 | 2021-08-10 | Kci Licensing, Inc. | Methods for preparing a skin graft |
US11103275B2 (en) * | 2010-12-17 | 2021-08-31 | Srgi Holdings, Llc | Pixel array medical systems, devices and methods |
WO2023064071A1 (en) * | 2021-10-12 | 2023-04-20 | Arthrex, Inc. | Surgical system and method for changing dimension of harvested tissue |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8617181B2 (en) | 2010-08-06 | 2013-12-31 | MoMelan Technologies, Inc. | Methods for preparing a skin graft |
US8562626B2 (en) | 2010-08-06 | 2013-10-22 | MoMelan Technologies, Inc. | Devices for harvesting a skin graft |
US9173674B2 (en) | 2010-08-06 | 2015-11-03 | MoMelan Technologies, Inc. | Devices for harvesting a skin graft |
WO2012145504A1 (en) * | 2011-04-20 | 2012-10-26 | Kci Licensing, Inc. | Skin graft devices and methods |
US10160946B2 (en) | 2013-09-13 | 2018-12-25 | University Of Florida Research Foundation, Inc. | Pluripotent tissue harvester and methods of manufacture thereof |
WO2015103045A1 (en) * | 2013-12-31 | 2015-07-09 | Kci Licensing, Inc. | Hydraulically actuated skin graft harvesting |
CN106108984B (en) * | 2016-09-09 | 2018-09-11 | 福州大学 | A kind of personalized negative pressure sucker preparation method of leucoderma skin-grafting |
JP2019532769A (en) * | 2016-10-28 | 2019-11-14 | ザ ジェネラル ホスピタル コーポレイション | Systems and methods for assembling tissue grafts |
US11633188B2 (en) | 2017-07-26 | 2023-04-25 | Neuraptive Therapeutics, Inc. | Device and method of creating a fluid containment field for administering therapeutics to a nerve |
CN109893217A (en) * | 2017-12-11 | 2019-06-18 | 中国人民解放军第二军医大学 | Skin-grafting skin graft mixing arrangement |
CN107961061A (en) * | 2017-12-19 | 2018-04-27 | 济南磐升生物技术有限公司 | A kind of autologous skin wound therapeutical devices |
US11193858B2 (en) | 2018-05-01 | 2021-12-07 | Community Blood Center | Tissue planing assemblies and methods |
RU2768156C1 (en) * | 2021-05-31 | 2022-03-23 | Карина Игоревна Мелконян | Method for preparing porcine dermis for creating acellular dermal matrix in experiment |
Citations (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2379574A (en) | 1943-11-05 | 1945-07-03 | Claude R Wickard | Method of producing surgical bandages with improved elastic properties |
US3054404A (en) | 1961-08-14 | 1962-09-18 | Cicero P Meek | Skin graft applicator |
US3782387A (en) | 1972-02-29 | 1974-01-01 | R Falabella | Apparatus and methods for obtaining and making skin grafts |
US4666447A (en) | 1985-01-30 | 1987-05-19 | Mentor Corporation | Skin expansion device and method of making the same |
US4773418A (en) | 1982-12-22 | 1988-09-27 | Rolf Hettich | Method for manufacturing a transplant |
US5015584A (en) | 1987-10-14 | 1991-05-14 | Board Of Regents, The University Of Texas System | Epidermal graft system |
WO1992011879A1 (en) | 1991-01-09 | 1992-07-23 | Principal Ab | Transdermal perfusion of fluids |
US5460939A (en) | 1986-04-18 | 1995-10-24 | Advanced Tissue Sciences, Inc. | Temporary living skin replacement |
WO1995028886A1 (en) | 1994-04-21 | 1995-11-02 | Medchem Products, Inc. | Skin stretching device |
US5476478A (en) | 1994-04-18 | 1995-12-19 | Providence Hospital | Preoperative skin stretching apparatus and method |
US5489304A (en) | 1994-04-19 | 1996-02-06 | Brigham & Women's Hospital | Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft |
WO1996018432A1 (en) | 1994-12-16 | 1996-06-20 | Gelbfish Gary A | Method and associated device for removing material from body |
US5545222A (en) | 1991-08-12 | 1996-08-13 | Bonutti; Peter M. | Method using human tissue |
WO1996033768A2 (en) | 1995-04-27 | 1996-10-31 | Svedman Paul | Suction blister sampling |
US5571098A (en) | 1994-11-01 | 1996-11-05 | The General Hospital Corporation | Laser surgical devices |
WO1997020509A2 (en) | 1995-12-07 | 1997-06-12 | L.R. Surgical Instruments Ltd. | An adjustable skin mesher device and a system for using the same |
US5686303A (en) | 1994-12-30 | 1997-11-11 | Korman; Joshua | Method of growing vertebrate skin in vitro |
WO1998016158A1 (en) | 1996-10-15 | 1998-04-23 | Burncare Bv | Method and instruments for forming skin grafts |
US5921980A (en) | 1997-12-03 | 1999-07-13 | University Of Kentucky Research Foundation | Laser skin graft harvesting apparatus and related method |
US6056738A (en) | 1997-01-31 | 2000-05-02 | Transmedica International, Inc. | Interstitial fluid monitoring |
US6071247A (en) | 1996-07-21 | 2000-06-06 | Kennedy; William R. | Skin blister biopsy apparatus and method |
US6358260B1 (en) | 1998-04-20 | 2002-03-19 | Med-Logics, Inc. | Automatic corneal shaper with two separate drive mechanisms |
US6402770B1 (en) | 1998-06-01 | 2002-06-11 | Avatar Design & Development, Inc. | Method and apparatus for placing and maintaining a percutaneous tube into a body cavity |
WO2003020333A2 (en) | 2001-08-29 | 2003-03-13 | Artemis Medical, Inc. | Undamaged tissue collection assembly and method |
WO2003039382A2 (en) | 2001-11-05 | 2003-05-15 | Medgenics, Inc. | System for processing tissue |
US6623498B1 (en) | 1999-02-10 | 2003-09-23 | Sis Ltd. | Cutting instrument |
US20040097967A1 (en) | 2000-10-27 | 2004-05-20 | Ignon Roger G. | Method for skin/surface abrasion |
WO2004071313A2 (en) | 2003-02-10 | 2004-08-26 | Applied Tissue Technologies, Llc | Apparatus for dermal tissue harvesting |
US20040172045A1 (en) | 2002-09-28 | 2004-09-02 | Elof Eriksson | System and method for transplantation of dermal tissue |
WO2004075764A1 (en) | 2003-02-27 | 2004-09-10 | Applied Tissue Technologies Llc | Method and apparatus for processing dermal tissue |
WO2004078032A2 (en) | 2003-03-03 | 2004-09-16 | Kci Licensing, Inc. | Tissue processing system |
US6800282B1 (en) | 1997-06-26 | 2004-10-05 | Smith & Nephew, Plc | Cell culture products |
US20040215217A1 (en) * | 2001-10-01 | 2004-10-28 | The Cleveland Clinic Foundation | Skin lesion exciser and skin-closure device therefor |
US20040237744A1 (en) | 2003-06-02 | 2004-12-02 | Chien-Fu Lin | Photo cutting apparatus |
WO2004105576A2 (en) | 2003-05-21 | 2004-12-09 | Kci Licensing, Inc. | Tissue harvesting device and method |
US20050038520A1 (en) | 2003-08-11 | 2005-02-17 | Francois Binette | Method and apparatus for resurfacing an articular surface |
US6860904B2 (en) | 1991-08-12 | 2005-03-01 | Bonutti 2003 Trust-A | Method for tissue grafting |
US20050101972A1 (en) | 2003-11-06 | 2005-05-12 | University Of Florida Research Foundation, Inc. | Devices and systems for separating and preparing skin |
US20060141616A1 (en) | 2004-12-28 | 2006-06-29 | Yeou-Bin Guu | Cell colonies dissecting and transplanting apparatus |
US7078582B2 (en) | 2001-01-17 | 2006-07-18 | 3M Innovative Properties Company | Stretch removable adhesive articles and methods |
US20060271070A1 (en) | 2003-02-27 | 2006-11-30 | Elof Eriksson | Method and apparatus for processing dermal tissue |
US7208006B2 (en) | 2002-03-01 | 2007-04-24 | Wilhelm Fleischmann | Process and instrument for stretching tissue of skin |
US7244444B2 (en) | 2004-03-31 | 2007-07-17 | Cook Incorporated | Graft material, stent graft and method |
US7540875B2 (en) | 1998-06-01 | 2009-06-02 | Avatar Design & Development, Inc. | Surgical cutting tool with automatically retractable blade assembly |
US20100012311A1 (en) | 2006-07-18 | 2010-01-21 | Airbus France | Heat flow device |
US7666192B2 (en) | 2001-02-16 | 2010-02-23 | Kci Licensing, Inc. | Skin grafting devices and methods |
WO2010036788A2 (en) | 2008-09-24 | 2010-04-01 | The General Hospital Corporation | Method and apparatus for grafting of skin tissue |
US20100152750A1 (en) | 2006-09-14 | 2010-06-17 | Omeed Memar | Apparatus and Methods for Repairing Tissue Defects |
US20110077664A1 (en) | 2009-09-28 | 2011-03-31 | Wright Medical Technology, Inc. | Device for processing dermal tissue |
WO2011059441A1 (en) | 2009-11-13 | 2011-05-19 | Smith & Nephew, Inc. | Mesher |
WO2011075676A2 (en) | 2009-12-18 | 2011-06-23 | Knowlton Edward W | A skin treatment and drug delivery device |
US20110251602A1 (en) | 2008-04-01 | 2011-10-13 | The General Hospital Corporation | Method and apparatus for tissue expansion |
US20120035599A1 (en) | 2010-08-06 | 2012-02-09 | MoMelan Technologies, Inc. | Devices for harvesting a skin graft |
US20120035618A1 (en) | 2010-08-06 | 2012-02-09 | MoMelan Technologies, Inc. | Methods for preparing a skin graft |
WO2012019098A1 (en) | 2010-08-06 | 2012-02-09 | MoMelan Technologies, Inc. | Methods for preparing a skin graft without culturing or use of biologics |
WO2012019096A1 (en) | 2010-08-06 | 2012-02-09 | MoMelan Technologies, Inc. | Methods for applying a skin graft |
US20120041430A1 (en) | 2008-04-01 | 2012-02-16 | The General Hospital Corporation | Method and apparatus for tissue grafting |
US20120172894A1 (en) | 2010-08-06 | 2012-07-05 | MoMelan Technologies, Inc. | Devices for harvesting a skin graft |
WO2012102812A1 (en) | 2011-01-27 | 2012-08-02 | MoMelan Technologies, Inc. | Device for generating and transferring micrografts and methods of use thereof |
US20120201793A1 (en) | 2001-11-05 | 2012-08-09 | Bellomo Stephen F | Dermal micro-organs, methods and apparatuses for producing and using the same |
US20120271320A1 (en) | 2011-04-20 | 2012-10-25 | Kci Licensing, Inc. | Skin graft devices and methods |
US20130041385A1 (en) | 2011-08-10 | 2013-02-14 | Joseph Giovannoli | Apparatus for skin reduction |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU772544A1 (en) * | 1979-01-04 | 1980-10-23 | Тартусский Ордена Трудового Красного Знамени Государственный Университет | Dermatome |
JPS61106142A (en) * | 1984-10-30 | 1986-05-24 | ゼリア新薬工業株式会社 | Skin peeling appliance |
JPH0317845Y2 (en) * | 1988-11-08 | 1991-04-16 | ||
US5792173A (en) * | 1995-07-10 | 1998-08-11 | Stuart D. Edwards | Wound closure hemostasis device |
KR970068994A (en) * | 1996-04-19 | 1997-11-07 | 한승경 | Inhalation Blister Formation Device and Inhalation Blister Formation for Transplantation of Epidermal Transplant Surgery |
CN2596950Y (en) * | 2003-02-24 | 2004-01-07 | 孙文红 | Epiderm extraction apparatus |
US20040181950A1 (en) * | 2003-03-17 | 2004-09-23 | Rodgers Murray Steven | Alignment of microkeratome blade to blade handle |
US7169115B2 (en) * | 2003-09-29 | 2007-01-30 | Ethicon Endo-Surgery, Inc. | Endoscopic mucosal resection device with overtube and method of use |
CN101053528A (en) * | 2007-06-01 | 2007-10-17 | 张磊 | Suction nozzle capable of separating large surface of skin |
JP2010212017A (en) * | 2009-03-09 | 2010-09-24 | Japan Aviation Electronics Industry Ltd | Electric connector |
-
2010
- 2010-08-06 US US12/851,621 patent/US8617181B2/en active Active
-
2011
- 2011-08-05 JP JP2013523358A patent/JP5878173B2/en not_active Expired - Fee Related
- 2011-08-05 CN CN201610416674.9A patent/CN105997199B/en active Active
- 2011-08-05 CN CN201180046197.7A patent/CN103402446B/en active Active
- 2011-08-05 CA CA2807411A patent/CA2807411C/en active Active
- 2011-08-05 BR BR112013002642-1A patent/BR112013002642B1/en active IP Right Grant
- 2011-08-05 SG SG2013006390A patent/SG187216A1/en unknown
- 2011-08-05 WO PCT/US2011/046737 patent/WO2012019094A2/en active Application Filing
- 2011-08-05 KR KR1020137005595A patent/KR101880313B1/en active IP Right Grant
- 2011-08-05 EP EP11815367.5A patent/EP2600779B1/en active Active
- 2011-08-05 KR KR1020187020063A patent/KR20180085048A/en not_active Application Discontinuation
-
2016
- 2016-06-21 AU AU2016204210A patent/AU2016204210B2/en not_active Revoked
-
2018
- 2018-10-31 AU AU2018256579A patent/AU2018256579A1/en not_active Abandoned
Patent Citations (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2379574A (en) | 1943-11-05 | 1945-07-03 | Claude R Wickard | Method of producing surgical bandages with improved elastic properties |
US3054404A (en) | 1961-08-14 | 1962-09-18 | Cicero P Meek | Skin graft applicator |
US3782387A (en) | 1972-02-29 | 1974-01-01 | R Falabella | Apparatus and methods for obtaining and making skin grafts |
US4773418A (en) | 1982-12-22 | 1988-09-27 | Rolf Hettich | Method for manufacturing a transplant |
US4666447A (en) | 1985-01-30 | 1987-05-19 | Mentor Corporation | Skin expansion device and method of making the same |
US5460939A (en) | 1986-04-18 | 1995-10-24 | Advanced Tissue Sciences, Inc. | Temporary living skin replacement |
US5015584A (en) | 1987-10-14 | 1991-05-14 | Board Of Regents, The University Of Texas System | Epidermal graft system |
WO1992011879A1 (en) | 1991-01-09 | 1992-07-23 | Principal Ab | Transdermal perfusion of fluids |
US5441490A (en) | 1991-01-09 | 1995-08-15 | Principal Ab | Transdermal perfusion of fluids |
US5441490B1 (en) | 1991-01-09 | 1997-09-16 | Svedman Paul | Transdermal perfusion of fluids |
US6860904B2 (en) | 1991-08-12 | 2005-03-01 | Bonutti 2003 Trust-A | Method for tissue grafting |
US5888219A (en) | 1991-08-12 | 1999-03-30 | Bonutti; Peter M. | Method of using human tissue with a tissue press and system |
US5545222A (en) | 1991-08-12 | 1996-08-13 | Bonutti; Peter M. | Method using human tissue |
US5476478A (en) | 1994-04-18 | 1995-12-19 | Providence Hospital | Preoperative skin stretching apparatus and method |
US5489304A (en) | 1994-04-19 | 1996-02-06 | Brigham & Women's Hospital | Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft |
WO1995028886A1 (en) | 1994-04-21 | 1995-11-02 | Medchem Products, Inc. | Skin stretching device |
US5759193A (en) | 1994-04-21 | 1998-06-02 | Medchem Products, Inc. | Single needle skin stretching device |
US5571098A (en) | 1994-11-01 | 1996-11-05 | The General Hospital Corporation | Laser surgical devices |
WO1996018432A1 (en) | 1994-12-16 | 1996-06-20 | Gelbfish Gary A | Method and associated device for removing material from body |
US5730717A (en) | 1994-12-16 | 1998-03-24 | Gelbfish; Gary A. | Method and associated device for removing material from body |
US5686303A (en) | 1994-12-30 | 1997-11-11 | Korman; Joshua | Method of growing vertebrate skin in vitro |
US5914264A (en) | 1994-12-30 | 1999-06-22 | Reconstructive Technologies | Apparatus for growing vertebrate skin in vitro |
WO1996033768A2 (en) | 1995-04-27 | 1996-10-31 | Svedman Paul | Suction blister sampling |
US6254580B1 (en) | 1995-04-27 | 2001-07-03 | Pal Svedman | Suction blister sampling |
WO1997020509A2 (en) | 1995-12-07 | 1997-06-12 | L.R. Surgical Instruments Ltd. | An adjustable skin mesher device and a system for using the same |
US6063094A (en) | 1995-12-07 | 2000-05-16 | L.R. Surgical Instruments Ltd. | Adjustable skin mesher device and a system for using the same |
US6071247A (en) | 1996-07-21 | 2000-06-06 | Kennedy; William R. | Skin blister biopsy apparatus and method |
US6248114B1 (en) | 1996-10-15 | 2001-06-19 | Burncare B. V. | Method for forming skin grafts |
US20010029380A1 (en) | 1996-10-15 | 2001-10-11 | Ysebaert Willem Marie | Cutting table for forming skin grafts |
US6364908B1 (en) * | 1996-10-15 | 2002-04-02 | Burncare B.V. | Method and instruments for stretching skin grafts |
WO1998016158A1 (en) | 1996-10-15 | 1998-04-23 | Burncare Bv | Method and instruments for forming skin grafts |
US6056738A (en) | 1997-01-31 | 2000-05-02 | Transmedica International, Inc. | Interstitial fluid monitoring |
US6800282B1 (en) | 1997-06-26 | 2004-10-05 | Smith & Nephew, Plc | Cell culture products |
US5921980A (en) | 1997-12-03 | 1999-07-13 | University Of Kentucky Research Foundation | Laser skin graft harvesting apparatus and related method |
US6358260B1 (en) | 1998-04-20 | 2002-03-19 | Med-Logics, Inc. | Automatic corneal shaper with two separate drive mechanisms |
US20030009185A1 (en) | 1998-06-01 | 2003-01-09 | Jessen John W. | Method and apparatus for placing and maintaining a percutaneous tube into a body cavity |
US6402770B1 (en) | 1998-06-01 | 2002-06-11 | Avatar Design & Development, Inc. | Method and apparatus for placing and maintaining a percutaneous tube into a body cavity |
US7540875B2 (en) | 1998-06-01 | 2009-06-02 | Avatar Design & Development, Inc. | Surgical cutting tool with automatically retractable blade assembly |
US6623498B1 (en) | 1999-02-10 | 2003-09-23 | Sis Ltd. | Cutting instrument |
EP1614404A2 (en) | 1999-02-10 | 2006-01-11 | SIS AG, Surgical Instrument Systems | Blade assembly |
US20040097967A1 (en) | 2000-10-27 | 2004-05-20 | Ignon Roger G. | Method for skin/surface abrasion |
US7078582B2 (en) | 2001-01-17 | 2006-07-18 | 3M Innovative Properties Company | Stretch removable adhesive articles and methods |
US7666192B2 (en) | 2001-02-16 | 2010-02-23 | Kci Licensing, Inc. | Skin grafting devices and methods |
WO2003020333A2 (en) | 2001-08-29 | 2003-03-13 | Artemis Medical, Inc. | Undamaged tissue collection assembly and method |
US20040215217A1 (en) * | 2001-10-01 | 2004-10-28 | The Cleveland Clinic Foundation | Skin lesion exciser and skin-closure device therefor |
WO2003039382A2 (en) | 2001-11-05 | 2003-05-15 | Medgenics, Inc. | System for processing tissue |
US20120201793A1 (en) | 2001-11-05 | 2012-08-09 | Bellomo Stephen F | Dermal micro-organs, methods and apparatuses for producing and using the same |
US20070183974A1 (en) | 2001-11-05 | 2007-08-09 | Pearlman Andrew L | Method and apparatus for production of a skin graft and the graft produced thereby |
WO2003049783A2 (en) | 2001-11-05 | 2003-06-19 | Medgenics, Inc. | Device and methods for harvesting tissue samples of known geometry |
WO2003049626A1 (en) | 2001-11-05 | 2003-06-19 | Medgenics, Inc. | Method and apparatus for production of a skin graft and the graft produced thereby |
US7208006B2 (en) | 2002-03-01 | 2007-04-24 | Wilhelm Fleischmann | Process and instrument for stretching tissue of skin |
US7666134B2 (en) | 2002-09-28 | 2010-02-23 | Kci Licensing, Inc. | System and method for transplantation of dermal tissue |
US20040172045A1 (en) | 2002-09-28 | 2004-09-02 | Elof Eriksson | System and method for transplantation of dermal tissue |
US20100145360A1 (en) | 2002-09-28 | 2010-06-10 | Kci Licensing, Inc. | System and method for transplantation of dermal tissue |
US20040225309A1 (en) | 2003-02-10 | 2004-11-11 | Elof Eriksson | Apparatus and method for dermal tissue harvesting |
WO2004071313A2 (en) | 2003-02-10 | 2004-08-26 | Applied Tissue Technologies, Llc | Apparatus for dermal tissue harvesting |
US7708746B2 (en) | 2003-02-27 | 2010-05-04 | Wright Medical Technology, Inc. | Method and apparatus for processing dermal tissue |
US20060271070A1 (en) | 2003-02-27 | 2006-11-30 | Elof Eriksson | Method and apparatus for processing dermal tissue |
WO2004075764A1 (en) | 2003-02-27 | 2004-09-10 | Applied Tissue Technologies Llc | Method and apparatus for processing dermal tissue |
US8187285B2 (en) | 2003-02-27 | 2012-05-29 | Applied Tissue Technologies Llc | Method and apparatus for processing dermal tissue |
US7625384B2 (en) | 2003-02-27 | 2009-12-01 | Wright Medical Technology, Inc. | Method and apparatus for processing dermal tissue |
US20040230215A1 (en) | 2003-02-27 | 2004-11-18 | Elof Eriksson | Method and apparatus for processing dermal tissue |
US20100042127A1 (en) | 2003-02-27 | 2010-02-18 | Wright Medical Technology, Inc. | Method and apparatus for processing dermal tissue |
US7926401B2 (en) | 2003-03-03 | 2011-04-19 | Kci Licensing, Inc. | Tissue harvesting device and method |
WO2004078032A2 (en) | 2003-03-03 | 2004-09-16 | Kci Licensing, Inc. | Tissue processing system |
US8109187B2 (en) | 2003-03-03 | 2012-02-07 | Kci Licensing, Inc. | Tissue harvesting device and method |
US8162957B2 (en) | 2003-03-03 | 2012-04-24 | Kci Licensing, Inc. | Tissue processing system |
US7651507B2 (en) | 2003-03-03 | 2010-01-26 | Kci Licensing, Inc. | Tissue processing system |
WO2004105576A2 (en) | 2003-05-21 | 2004-12-09 | Kci Licensing, Inc. | Tissue harvesting device and method |
US20040237744A1 (en) | 2003-06-02 | 2004-12-02 | Chien-Fu Lin | Photo cutting apparatus |
US20050038520A1 (en) | 2003-08-11 | 2005-02-17 | Francois Binette | Method and apparatus for resurfacing an articular surface |
WO2005033273A2 (en) | 2003-09-29 | 2005-04-14 | Kci Licensing, Inc. | System for transplantation of dermal tissue |
WO2005046428A2 (en) | 2003-11-06 | 2005-05-26 | University Of Florida Research Foundation, Inc. | Devices and systems for separating and preparing skin |
US20050101972A1 (en) | 2003-11-06 | 2005-05-12 | University Of Florida Research Foundation, Inc. | Devices and systems for separating and preparing skin |
US7244444B2 (en) | 2004-03-31 | 2007-07-17 | Cook Incorporated | Graft material, stent graft and method |
US20060141616A1 (en) | 2004-12-28 | 2006-06-29 | Yeou-Bin Guu | Cell colonies dissecting and transplanting apparatus |
WO2007117488A2 (en) | 2006-04-05 | 2007-10-18 | Applied Tissue Technologies, Llc | Method and apparatus for processing dermal tissue |
US20100012311A1 (en) | 2006-07-18 | 2010-01-21 | Airbus France | Heat flow device |
US20100152750A1 (en) | 2006-09-14 | 2010-06-17 | Omeed Memar | Apparatus and Methods for Repairing Tissue Defects |
US20120041430A1 (en) | 2008-04-01 | 2012-02-16 | The General Hospital Corporation | Method and apparatus for tissue grafting |
US20110251602A1 (en) | 2008-04-01 | 2011-10-13 | The General Hospital Corporation | Method and apparatus for tissue expansion |
US20110264115A1 (en) | 2008-09-24 | 2011-10-27 | The General Hospital Corporation | Method and apparatus for grafting of skin tissue |
WO2010036788A2 (en) | 2008-09-24 | 2010-04-01 | The General Hospital Corporation | Method and apparatus for grafting of skin tissue |
US20110077664A1 (en) | 2009-09-28 | 2011-03-31 | Wright Medical Technology, Inc. | Device for processing dermal tissue |
WO2011038326A1 (en) | 2009-09-28 | 2011-03-31 | Wright Medical Technology, Inc. | Device for processing dermal tissue |
WO2011059441A1 (en) | 2009-11-13 | 2011-05-19 | Smith & Nephew, Inc. | Mesher |
WO2011075676A2 (en) | 2009-12-18 | 2011-06-23 | Knowlton Edward W | A skin treatment and drug delivery device |
US20120035620A1 (en) * | 2010-08-06 | 2012-02-09 | MoMelan Technologies, Inc. | Methods for preparing a skin graft without culturing or use of biologics |
US20120172894A1 (en) | 2010-08-06 | 2012-07-05 | MoMelan Technologies, Inc. | Devices for harvesting a skin graft |
US20120035619A1 (en) * | 2010-08-06 | 2012-02-09 | MoMelan Technologies, Inc. | Methods for applying a skin graft |
WO2012019096A1 (en) | 2010-08-06 | 2012-02-09 | MoMelan Technologies, Inc. | Methods for applying a skin graft |
WO2012019098A1 (en) | 2010-08-06 | 2012-02-09 | MoMelan Technologies, Inc. | Methods for preparing a skin graft without culturing or use of biologics |
US20120035618A1 (en) | 2010-08-06 | 2012-02-09 | MoMelan Technologies, Inc. | Methods for preparing a skin graft |
WO2012019095A2 (en) | 2010-08-06 | 2012-02-09 | MoMelan Technologies, Inc. | Devices for harvesting a skin graft |
WO2012019094A2 (en) | 2010-08-06 | 2012-02-09 | MoMelan Technologies, Inc. | Methods for preparing a skin graft |
US20120035599A1 (en) | 2010-08-06 | 2012-02-09 | MoMelan Technologies, Inc. | Devices for harvesting a skin graft |
US20120197267A1 (en) | 2011-01-27 | 2012-08-02 | MoMelan Technologies, Inc. | Devices for generating and transferring micrografts and methods of use thereof |
WO2012102812A1 (en) | 2011-01-27 | 2012-08-02 | MoMelan Technologies, Inc. | Device for generating and transferring micrografts and methods of use thereof |
US20120271320A1 (en) | 2011-04-20 | 2012-10-25 | Kci Licensing, Inc. | Skin graft devices and methods |
WO2012145504A1 (en) | 2011-04-20 | 2012-10-26 | Kci Licensing, Inc. | Skin graft devices and methods |
US20130041385A1 (en) | 2011-08-10 | 2013-02-14 | Joseph Giovannoli | Apparatus for skin reduction |
Non-Patent Citations (9)
Title |
---|
Awad, Dermatol Surg, 34(9):1186-1193, 2008. |
International Search Report and Written Opinion dated Dec. 16, 2011 for International Application No. PCT/US11/46737, 9 pages. |
International Search Report and Written Opinion dated Dec. 16, 2011 for International Application No. PCT/US11/46738, 7 pages. |
International Search Report and Written Opinion dated Dec. 23, 2011 for International Application No. PCT/US11/46739, 7 pages. |
International Search Report and Written Opinion dated Dec. 6, 2011 for International Application No. PCT/US11/46741, 7 pages. |
Kreis et al., Burns, 20(1):S39-S42, 1994. |
Lari et al., Burns, 27:61-66, 2001. |
Meek, Am J Surg., 96(4):557-558, 1958. |
Mulekar et al., Dermatol Surg 25(1):66-71, 2009. |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11684388B2 (en) | 2008-09-24 | 2023-06-27 | The General Hospital Corporation | Method and apparatus for grafting of skin tissue |
US10278724B2 (en) | 2008-09-24 | 2019-05-07 | The General Hospital Corporation | Method and apparatus for grafting of skin tissue |
US9451979B2 (en) | 2008-09-24 | 2016-09-27 | The General Hospital Corporation | Method and apparatus for grafting of skin tissue |
US10537355B2 (en) | 2010-08-06 | 2020-01-21 | Kci Licensing, Inc. | Microblister skin grafting |
US9517082B2 (en) * | 2010-08-06 | 2016-12-13 | Kci Licensing, Inc. | Methods for preparing a skin graft without culturing or use of biologics |
US9610093B2 (en) | 2010-08-06 | 2017-04-04 | Kci Licensing, Inc. | Microblister skin grafting |
US11083487B2 (en) | 2010-08-06 | 2021-08-10 | Kci Licensing, Inc. | Methods for preparing a skin graft |
US10603072B2 (en) | 2010-08-06 | 2020-03-31 | Kci Licensing, Inc. | Methods for preparing a skin graft without culturing or use of biologics |
US11103275B2 (en) * | 2010-12-17 | 2021-08-31 | Srgi Holdings, Llc | Pixel array medical systems, devices and methods |
US9848908B2 (en) | 2011-12-07 | 2017-12-26 | Kci Licensing, Inc. | Devices for generating skin grafts |
US9962254B2 (en) | 2013-03-14 | 2018-05-08 | Kci Licensing, Inc. | Absorbent substrates for harvesting skin grafts |
US10463392B2 (en) | 2013-12-31 | 2019-11-05 | Kci Licensing, Inc. | Fluid-assisted skin graft harvesting |
US9993261B2 (en) | 2013-12-31 | 2018-06-12 | Kci Licensing, Inc. | Sensor systems for skin graft harvesting |
US10912861B2 (en) | 2015-04-09 | 2021-02-09 | Kci Licensing, Inc. | Soft-tack, porous substrates for harvesting skin grafts |
US11006974B2 (en) | 2015-11-03 | 2021-05-18 | Kci Licensing, Inc. | Devices for creating an epidermal graft sheet |
US10174279B2 (en) | 2015-11-19 | 2019-01-08 | Electronics And Telecommunications Research Institute | Apparatus and method for expanding skin |
WO2017143229A1 (en) | 2016-02-19 | 2017-08-24 | Kci Licensing, Inc. | Transfected epidermal grafts and methods of making the same |
WO2018102342A1 (en) | 2016-11-29 | 2018-06-07 | Kci Licensing, Inc. | Identification and visualization of micrografts for monitoring epithelialization |
WO2020223492A1 (en) * | 2019-04-30 | 2020-11-05 | Srgi Holdings Llc | Pixel array medical systems, devices and methods |
WO2023064071A1 (en) * | 2021-10-12 | 2023-04-20 | Arthrex, Inc. | Surgical system and method for changing dimension of harvested tissue |
Also Published As
Publication number | Publication date |
---|---|
SG187216A1 (en) | 2013-02-28 |
CN105997199A (en) | 2016-10-12 |
BR112013002642B1 (en) | 2021-02-02 |
EP2600779B1 (en) | 2016-09-21 |
KR101880313B1 (en) | 2018-07-19 |
CN105997199B (en) | 2019-08-02 |
RU2013107157A (en) | 2014-09-20 |
JP2013543387A (en) | 2013-12-05 |
KR20130094314A (en) | 2013-08-23 |
CN103402446B (en) | 2016-08-03 |
AU2018256579A1 (en) | 2018-11-22 |
US20120035618A1 (en) | 2012-02-09 |
EP2600779A2 (en) | 2013-06-12 |
AU2016204210A1 (en) | 2016-07-21 |
KR20180085048A (en) | 2018-07-25 |
BR112013002642A2 (en) | 2016-06-07 |
WO2012019094A3 (en) | 2013-08-15 |
AU2016204210B2 (en) | 2018-08-02 |
JP5878173B2 (en) | 2016-03-08 |
CA2807411C (en) | 2019-09-03 |
WO2012019094A2 (en) | 2012-02-09 |
EP2600779A4 (en) | 2014-05-28 |
CN103402446A (en) | 2013-11-20 |
CA2807411A1 (en) | 2012-02-09 |
AU2011285592A1 (en) | 2013-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10603072B2 (en) | Methods for preparing a skin graft without culturing or use of biologics | |
US8617181B2 (en) | Methods for preparing a skin graft | |
US11083487B2 (en) | Methods for preparing a skin graft | |
US9414856B2 (en) | Devices for generating and transferring micrografts and methods of use thereof | |
CA2857995C (en) | Methods of manufacturing devices for generating skin grafts | |
AU2011285592B2 (en) | Methods for preparing a skin graft | |
RU2587906C2 (en) | Methods of preparing a skin graft |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MOMELAN TECHNOLOGIES, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SABIR, SAMEER AHMED, MR.;TOLKOFF, M. JOSH, MR.;ZIEGLER, ANDREW, MR.;AND OTHERS;SIGNING DATES FROM 20110301 TO 20110314;REEL/FRAME:026015/0037 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: KINETIC CONCEPTS, INC., TEXAS Free format text: MERGER AND CHANGE OF NAME;ASSIGNORS:MOMELAN TECHNOLOGIES, INC.;KINETIC CONCEPTS, INC.;REEL/FRAME:038163/0834 Effective date: 20151222 Owner name: KCI LICENSING, INC., TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KCI HOLDING COMPANY, INC.;REEL/FRAME:038163/0900 Effective date: 20151231 Owner name: KCI HOLDING COMPANY, INC., TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KINETIC CONCEPTS, INC.;REEL/FRAME:038163/0853 Effective date: 20151231 |
|
AS | Assignment |
Owner name: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT, MINNESOTA Free format text: SECOND LIEN SECURITY AGREEMENT;ASSIGNORS:KCI USA, INC.;LIFECELL CORPORATION;KCI LICENSING, INC.;REEL/FRAME:040098/0268 Effective date: 20160920 Owner name: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATE Free format text: SECOND LIEN SECURITY AGREEMENT;ASSIGNORS:KCI USA, INC.;LIFECELL CORPORATION;KCI LICENSING, INC.;REEL/FRAME:040098/0268 Effective date: 20160920 |
|
AS | Assignment |
Owner name: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT, MINNESOTA Free format text: LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNORS:KCI USA, INC.;LIFECELL CORPORATION;KCI LICENSING, INC.;REEL/FRAME:040291/0237 Effective date: 20161006 Owner name: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATE Free format text: LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNORS:KCI USA, INC.;LIFECELL CORPORATION;KCI LICENSING, INC.;REEL/FRAME:040291/0237 Effective date: 20161006 |
|
AS | Assignment |
Owner name: KCI USA, INC., TEXAS Free format text: RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268;ASSIGNOR:WILMINGTON TRUST;REEL/FRAME:041666/0320 Effective date: 20170203 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
AS | Assignment |
Owner name: KCI USA, INC., TEXAS Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:050966/0547 Effective date: 20191011 Owner name: KCI LICENSING, INC., TEXAS Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:WILMINGTON TRUST, NATIONAL ASSOCIATION;REEL/FRAME:050966/0547 Effective date: 20191011 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 8 |
|
AS | Assignment |
Owner name: 3M INNOVATIVE PROPERTIES COMPANY, MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KCI LICENSING, INC.;REEL/FRAME:064718/0544 Effective date: 20230824 |
|
AS | Assignment |
Owner name: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY, MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:3M INNOVATIVE PROPERTIES COMPANY;REEL/FRAME:066443/0513 Effective date: 20240201 |